-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Abvc Biopharma, Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2014 to Q4 2024.
- Abvc Biopharma, Inc. Cost of Revenue for the quarter ending December 31, 2024 was $0.000, a 100% decline year-over-year.
- Abvc Biopharma, Inc. Cost of Revenue for the twelve months ending December 31, 2024 was $763.000, a 99.7% decline year-over-year.
- Abvc Biopharma, Inc. annual Cost of Revenue for 2024 was $763.000, a 99.7% decline from 2023.
- Abvc Biopharma, Inc. annual Cost of Revenue for 2023 was $302K, a 5.45% increase from 2022.
- Abvc Biopharma, Inc. annual Cost of Revenue for 2022 was $286K, a 5531% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)